Latest filing published 01 Sept 2023 for LifeMD, Inc., €50k.
Filing timeline
BuySaleInsider track record
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Bertrand Velge: trading record in brief
Bertrand Velge is a declared insider of LifeMD, Inc. (board member), with filings sourced from SEC (Form 4). We count 16 filings; the first trade dates from 15 April 2020 and the latest from 31 August 2023.
Every open-market trade on record is a purchase: 14 purchases worth €1.7M, and no sale. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Outside the open market, there are 2 share grants. 2023 to date brings 10 purchases and no sales.
The median purchase comes to €103k. 8 out of 11 purchases came within 30 days of a purchase by at least one other insider of the same company. Purchases made close together by different insiders form what is called a cluster.
The newest entry dates from 1 September 2023: an open-market purchase of €121k, in LifeMD, Inc. Filings reach the SEC (Form 4) feed a median of 3 days after the trade. Section 16 rules allow two business days to file each Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Bertrand Velge
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 24,500 shares@ US$2.185611.8% of flowCommon StockSEC:0001362118-23-000054:0Canonical exit: 5 Sept 2023 (T+90)
- 10,000 shares0Common StockSEC:0001362118-23-000053:0
- 3,945 shares@ US$2.93532.5% of flowCommon StockSEC:0001362118-23-000040:0Canonical exit: 12 Sept 2023 (T+90)
- 24,500 shares@ US$2.185611.8% of flowCommon StockSEC:0001362118-23-000038:0Canonical exit: 5 Sept 2023 (T+90)
- 10,383 shares@ US$2.16514.9% of flowCommon StockSEC:0001362118-23-000036:0Canonical exit: 3 Sept 2023 (T+90)
- 25,000 shares@ US$4.5455.2% of flowCommon StockSEC:0001362118-21-000052:0Canonical exit: 7 Mar 2022 (T+90)
- 294,118 shares@ US$0.170.028% mcap15.7% of flowCommon StockSEC:0001362118-21-000051:0Canonical exit: 14 Jul 2020 (T+90)
7 of 7 declarations
